Mutations in PIK3CA affect glucose metabolism and proliferation in cervical cancer by activating the AKT/glycogen synthase kinase 3β/β-catenin signalling pathway [13], thereby reversing resistance to radiotherapy [14]. The gene discussed is PIK3CA; the disease is cervical carcinoma.